We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+16.03%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.54B
AUM Growth
+$60.9M
Cap. Flow
+$74M
Cap. Flow %
4.8%
Top 10 Hldgs %
54%
Holding
195
New
45
Increased
24
Reduced
23
Closed
33

Sector Composition

Rank Sector Weight
1 Healthcare 15%
2 Communication Services 10.95%
3 Consumer Discretionary 9.25%
4 Financials 3.04%
5 Utilities 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCON
51
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$5.62M 0.36%
13,695
SQBG
52
DELISTED
Sequential Brands Group, Inc.
SQBG
$5.61M 0.36%
83,905
STNG icon
53
Scorpio Tankers
STNG
$3.76B
$5.56M 0.36%
+276,744
New +$6.01M
MDCO
54
DELISTED
Medicines Co
MDCO
$5M 0.32%
167,252
+40,000
+31% +$1.51M
ADMA icon
55
ADMA Biologics
ADMA
$2.01B
$5M 0.32%
805,000
-80,000
-9% -$461K
MDLZ icon
56
PUT
Mondelez International
MDLZ
$80.5B
$5M 0.32%
+100,000
New +$4.27M
CFRX
57
DELISTED
ContraFect Corporation
CFRX
$4.72M 0.31%
2,850
-56
-2% -$92.7K
INSE icon
58
Inspired Entertainment
INSE
$182M
$4.63M 0.3%
758,430
+51,100
+7% +$341K
MYGN icon
59
PUT
Myriad Genetics
MYGN
$507M
$4.6M 0.3%
+100,000
New +$4.45M
SNDX icon
60
Syndax Pharmaceuticals
SNDX
$1.73B
$4.21M 0.27%
521,000
+146,000
+39% +$1.04M
MFAC.U
61
DELISTED
Megalith Financial Acquisition Corp. Units, each consisting of one share of Class A Common Stock, an
MFAC.U
$4.04M 0.26%
+400,000
New +$4.02M
PTE
62
DELISTED
PolarityTE, Inc. Common Stock
PTE
$3.11M 0.2%
6,520
-280
-4% -$161K
SRRA
63
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$3.06M 0.2%
45,000
FMCIU
64
DELISTED
Forum Merger II Corporation Unit
FMCIU
$3.04M 0.2%
+300,000
New +$3.01M
DMK
65
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$2.98M 0.19%
+12,143
New +$2.88M
KRE icon
66
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.49B
$2.97M 0.19%
50,000
-250,000
-83% -$15.6M
MDC
67
PUT
DELISTED
M.D.C. Holdings, Inc.
MDC
$2.96M 0.19%
116,640
TWNKW
68
DELISTED
Hostess Brands, Inc. Warrants
TWNKW
$2.84M 0.18%
2,680,000
+453,201
+20% +$727K
ARDX icon
69
Ardelyx
ARDX
$1.25B
$2.83M 0.18%
650,000
TGTX icon
70
TG Therapeutics
TGTX
$8.19B
$2.8M 0.18%
+500,000
New +$5.71M
GGAL icon
71
Galicia Financial Group
GGAL
$8.29B
$2.67M 0.17%
105,000
+60,000
+133% +$1.82M
AGRO icon
72
Adecoagro
AGRO
$1.47B
$2.57M 0.17%
350,000
ZGNX
73
DELISTED
Zogenix, Inc.
ZGNX
$2.48M 0.16%
50,000
ELLI
74
PUT
DELISTED
Ellie Mae Inc
ELLI
$2.37M 0.15%
25,000
OTIC
75
DELISTED
Otonomy, Inc.
OTIC
$2.2M 0.14%
800,000

Similar funds

683 Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, 683 Capital Management held 195 positions worth $1.54B, up 4.1% from $1.48B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

683 Capital Management deployed $74M of net new capital in Q3 2018, opening 45 new positions and adding to 24 existing holdings. Its largest new stake was Scorpio Tankers: 276,744 shares worth $5.56M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was PG&E, an estimated $3.56M trimmed.

  • 683 Capital Management's largest Q3 2018 buy was Scorpio Tankers: 276,744 shares worth $5.56M.
  • 683 Capital Management added most to Redhill Biopharma in Q3 2018, an estimated $12.9M increase.
  • 683 Capital Management's biggest Q3 2018 reduction was PG&E, cutting an estimated $3.56M.
  • 683 Capital Management fully exited Hycroft Mining Holding Corp in Q3 2018, selling an estimated $18.3M.
  • 683 Capital Management's ten largest holdings make up 54% of its $1.54B portfolio in Q3 2018.
  • 683 Capital Management opened 45 new positions and closed 33 in Q3 2018.
  • 683 Capital Management's portfolio value rose 4.1% quarter-over-quarter to $1.54B.

Based on 683 Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.